28 results on '"Moylan, Jennifer S."'
Search Results
2. Sphingomyelinase stimulates oxidant signaling to weaken skeletal muscle and promote fatigue
- Author
-
Ferreira, Leonardo F., Moylan, Jennifer S., Gilliam, Laura A.A., Smith, Jeffrey D., Nikolova-Karakashian, Mariana, and Reid, Michael B.
- Subjects
Muscles -- Health aspects ,Fatigue -- Health aspects ,Hydrolases -- Chemical properties ,Hydrolases -- Health aspects ,Enzymes -- Chemical properties ,Enzymes -- Health aspects ,Oxidizing agents -- Chemical properties ,Oxidizing agents -- Health aspects ,Biological sciences - Abstract
Sphingomyelinase (SMase) hydrolyzes membrane sphingomyelin into ceramide, which increases oxidants in nonmuscle cells. Serum SMase activity is elevated in sepsis and heart failure, conditions where muscle oxidants are increased, maximal muscle force is diminished, and fatigue is accelerated. We tested the hypotheses that exogenous SMase and accumulation of ceramide in muscle increases oxidants in muscle cells, depresses specific force of unfatigued muscle, and accelerates the fatigue process. We also anticipated that the antioxidant N-acetylcysteine (NAC) would prevent SMase effects on muscle function. We studied the responses of C2C12 myotubes and mouse diaphragm to SMase treatment in vitro. We observed that SMase caused a 2.8-fold increase in total ceramide levels in myotubes. Exogenous ceramide and SMase elevated oxidant activity in C2C12 myotubes by 15-35% (P < 0.05) and in diaphragm muscle fiber bundles by 58-120% (P < 0.05). The SMase-induced increase in diaphragm oxidant activity was prevented by NAC. Exogenous ceramide depressed diaphragm force by 55% (P < 0.05), while SMase depressed maximal force by 30% (P < 0.05) and accelerated fatigue--effects opposed by treatment with NAC. In conclusion, our findings suggest that SMase stimulates a ceramide-oxidant signaling pathway that results in muscle weakness and fatigue. exercise; oxidative stress; ceramide; diaphragm; inflammation doi: 10.1152/ajpcell.00065.2010.
- Published
- 2010
3. Interleukin- 1 stimulates catabolism in C2C12 myotubes
- Author
-
Li, Wei, Moylan, Jennifer S., Chambers, Melissa A., Smith, Jeffrey, and Reid, Michael B.
- Subjects
Cell metabolism -- Genetic aspects ,Cell metabolism -- Physiological aspects ,Interleukin-1 -- Physiological aspects ,Interleukin-1 -- Research ,Muscle proteins -- Physiological aspects ,Muscle proteins -- Genetic aspects ,Muscle proteins -- Research ,Ubiquitin-proteasome system -- Physiological aspects ,Ubiquitin-proteasome system -- Genetic aspects ,Ubiquitin-proteasome system -- Research ,Biological sciences - Abstract
Interleukin- 1 (IL- 1) is an inflammatory cytokine that has been linked to muscle catabolism, a process regulated by muscle-specific E3 proteins of the ubiquitin-proteasome pathway. To address cellular mechanism, we tested the hypothesis that IL-1 induces myofibrillar protein loss by acting directly on muscle to increase expression of two critical E3 proteins, atrogin1/ muscle atrophy F-box (MAFbx) and muscle RING-finger 1 (MuRF1). Experiments were conducted using mature C2C 12 myotubes to eliminate systemic cytokine effects and avoid paracrine signaling by nonmuscle cell types. Time-course protocols were used to define the sequence of cellular responses. We found that atrogin1/MAFbx mRNA and MuRF1 mRNA are elevated 60-120 rain after myotube exposure to either IL-1[alpha] or IL-1[beta]. These responses are preceded by signaling events that promote E3 expression. Both IL-1 isoforms stimulate phosphorylation of p38 mitogen-activated protein kinase and stimulate nuclear factor-[kappa]B (NF-[kappa]B) signaling; I-[kappa]B levels fall and NF-[kappa]B DNA binding activity increases. Other regulators of E3 expression are unaffected by IL-1 [cytosolic oxidant activity, Fork-head-O (Foxo) activity] or respond paradoxically (AKT). Chronic exposure of C2C12 myotubes over 48 h resulted in reduced myotube width and loss of sarcomeric actin. We conclude that IL- 1[alpha] and IL-1[beta] act via an oxidant- and AKT/Foxo-independent mechanism to activate p38 MAPK, stimulate NF-[kappa]B signaling, increase expression of atrogin1/MAFbx and MuRF1, and reduce myofibrillar protein in differentiated myotubes. skeletal muscle; atrophy; cachexia; cytokines; inflammation
- Published
- 2009
4. TNF induction of atrogin-1/MAFbx mRNA depends on Foxo4 expression but not AKT-Foxo1/3 signaling
- Author
-
Moylan, Jennifer S., Smith, Jeffrey D., Chambers, Melissa A., McLoughlin, Thomas J., and Reid, Michael B.
- Subjects
Atrophy, Muscular -- Development and progression ,Biological sciences - Abstract
Murine models of starvation-induced muscle atrophy demonstrate that reduced protein kinase B (AKT) function upregulates the atrophy-related gene atrogin-1/ MAFbx (atrogin). The mechanism involves release of inhibition of Forkhead transcription factors, namely Foxo1 and Foxo3. Elevated atrogin mRNA also corresponds with elevated TNF in inflammatory catabolic states, including cancer and chronic heart failure. Exogenous tumor necrosis factor (TNF) increases atrogin mRNA in vivo and in vitro. We used TNF-treated C2C12 myotubes to test the hypothesis that AKT-Foxo1/3 signaling mediates TNF regulation of atrogin mRNA. Here we confirm that exposure to TNF increases atrogin mRNA (+125%). We also confirm that canonical AKT-mediated regulation of atrogin is active in C2C12 myotubes. Inhibition of phosphoinositol-3 kinase (PI3K)/AKT signaling with wortmannin reduces AKT phosphorylation (-87%) and increases atrogin mRNA (+340%). Activation with insulin-like growth factor (IGF) increases AKT phosphorylation (+126%) and reduces atrogin mRNA (-15%). Although AKT regulation is intact, our data suggest it does not mediate TNF effects on atrogin. TNF increases AKT phosphorylation (+50%) and stimulation of AKT with IGF does not prevent TNF induction of atrogin mRNA. Nor does TNF appear to signal through Foxo1/3 proteins. TNF has no effect on Foxo1/3 mRNA or Foxo1/3 nuclear localization. Instead, TNF increases nuclear Foxo4 protein (+55%). Small interfering RNA oligos targeted to two distinct regions of Foxo4 mRNA reduce the TNF-induced increase in atrogin mRNA (-34% and -32%). We conclude that TNF increases atrogin mRNA independent of AKT via Foxo4. These results suggest a mechanism by which inflammatory catabolic states may persist in the presence of adequate growth factors and nutrition. skeletal muscle; cachexia; atrophy; ubiquitin; cytokines
- Published
- 2008
5. IFN-[gamma] does not mimic the catabolic effects of TNF-[alpha]
- Author
-
Smith, Melissa A., Moylan, Jennifer S., Smith, Jeffrey D., Li, Wei, and Reid, Michael B.
- Subjects
Interferon gamma -- Dosage and administration ,Interferon gamma -- Research ,Muscle cells -- Health aspects ,Muscle cells -- Research ,Tumor necrosis factor -- Health aspects ,Tumor necrosis factor -- Research ,Biological sciences - Abstract
Cachexia is common in chronic inflammatory diseases and is attributed, in part, to an elevation of circulating proinflammatory cytokines. TNF-[alpha] is the prototype in this category, IFN-[gamma] is also thought to play a role, but the evidence supporting this model is primarily indirect. To determine the direct effects of IFN-[gamma] stimulation on muscle cells, we selected key components of the procatabolic signaling pathways by which TNF-[alpha] stimulates protein loss. We tested two hypotheses: 1) IFN-[gamma] mimics TNF-[alpha] signaling by increasing intracelhilar oxidant activity and activating MAPKs and NF-[kappa]B and 2) IFN-[gamma] increases the expression of the ubiquitin ligases atroginl/MAFbx and muscle-specific ring finger protein 1 (MuRF1). Results showed that treatment with IFN-[gamma] at 60 ng/ml increased Statl phosphorylation after 15 min, indicating receptor activation. IFN-[gamma] had no effect on cytosolic oxidant activity, as measured by 2',7'-dichlorofluorescein oxidation. Nor did IFN-[gamma] activate JNK, ERK1/2, or p38 MAPK, as assessed by Western blot. Treatment for up to 60 min did not decrease I[kappa]B-[alpha] protein levels, as measured by Western blot analysis, or the DNA binding activity of NF-[kappa]B, as measured by EMSA. After 6 h, IFN-[gamma] decreased Akt phosphorylation and increased atrogin1/MAFbx and MuRF1 mRNA. Daily treatment for up to 72 h did not alter adult fast-type myosin heavy chain content or the total protein-to-DNA ratio. These data show that responses of myotubes to IFN-[gamma] and TNF-[alpha] differ markedly and provide little evidence for a direct catabolic effect of IFN-[gamma] on muscle. skeletal muscle; cachexia; oxidative stress; C2Cl2; atrophy; tumor necrosis factor-[alpha]; interferon-[gamma];
- Published
- 2007
6. Beyond atrophy: redox mechanisms of muscle dysfunction in chronic inflammatory disease
- Author
-
Reid, Michael B. and Moylan, Jennifer S.
- Published
- 2011
- Full Text
- View/download PDF
7. DOXORUBICIN CAUSES DIAPHRAGM WEAKNESS IN MURINE MODELS OF CANCER CHEMOTHERAPY
- Author
-
Gilliam, Laura A.A., Moylan, Jennifer S., Callahan, Leigh Ann, Sumandea, Marius P., and Reid, Michael B.
- Published
- 2011
- Full Text
- View/download PDF
8. Stretch-stimulated glucose uptake in skeletal muscle is mediated by reactive oxygen species and p38 MAP-kinase
- Author
-
Chambers, Melissa A., Moylan, Jennifer S., Smith, Jeffrey D., Goodyear, Laurie J., and Reid, Michael B.
- Published
- 2009
- Full Text
- View/download PDF
9. OXIDATIVE STRESS, CHRONIC DISEASE, AND MUSCLE WASTING
- Author
-
Moylan, Jennifer S. and Reid, Michael B.
- Published
- 2007
- Full Text
- View/download PDF
10. Degree of Agreement Between Infant Serum and Salivary Concentration of Leptin and Adiponectin and Its Association With Infants' Feeding.
- Author
-
Linares, Ana M., Rayens, Mary Kay, Moylan, Jennifer S., and Miller, Craig S.
- Subjects
SALIVA analysis ,REFERENCE values ,INFANT formulas ,BIOMARKERS ,MOTHERS ,STATISTICS ,ARTIFICIAL feeding ,CONFIDENCE intervals ,LEPTIN ,INFANT nutrition ,COMPARATIVE studies ,T-test (Statistics) ,ADIPONECTIN ,RESEARCH funding ,REPEATED measures design ,BREASTFEEDING ,DESCRIPTIVE statistics ,CHI-squared test ,DATA analysis software ,DATA analysis ,LONGITUDINAL method ,CHILDREN - Abstract
Background: Leptin and adiponectin, two adipokines involved in glucose and lipid metabolism, have been linked to regulation of growth in early infancy, energy balance, and metabolic disorders in childhood. The aim of this study was to determine if concentrations of leptin and adiponectin could be measured reliably in infants' saliva, to evaluate the degree of agreement with infant serum levels, and to explore their association with infant feeding status. Methods: A total of 34 infants were recruited after birth and followed for 20 weeks. After log-transformation of the values, a Bland-Altman graphical approach was used to summarize the direction of the difference between the serum and saliva values. Repeated measures mixed modeling was used to evaluate differences over time in these outcomes by feeding status. Results: Mean concentration of salivary leptin and adiponectin in infants was 3.7 (SD =.8) ng/mL and 2.9 (SD = 0.7) ng/mL, respectively. The degree of agreement between serum and saliva for log-transformed leptin and adiponectin values were relatively robust, albeit with a non-zero bias between the two methods, given that serum values were greater than corresponding saliva values for both adipokines in all infants. Each of the four repeated measures mixed models (one for each adipokine measure) had a significant main effect; however, the interaction between time and feeding status was not significant in any of the models. Conclusion: This study demonstrated that leptin and adiponectin can be measured in infant saliva, but in some cases leptin concentrations may be more difficult to detect. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
11. Diaphragm Abnormalities in Patients with End-Stage Heart Failure: NADPH Oxidase Upregulation and Protein Oxidation.
- Author
-
Ahn, Bumsoo, Coblentz, Philip D., Beharry, Adam W., Patel, Nikhil, Judge, Andrew R., Moylan, Jennifer. S., Hoopes, Charles W., Bonnell, Mark R., and Ferreira, Leonardo F.
- Subjects
HEART failure patients ,REACTIVE oxygen species ,MORTALITY ,NADPH oxidase ,PHOSPHORYLATION ,MESSENGER RNA - Abstract
Patients with heart failure (HF) have diaphragm abnormalities that contribute to disease morbidity and mortality. Studies in animals suggest that reactive oxygen species (ROS) cause diaphragm abnormalities in HF. However, the effects of HF on ROS sources, antioxidant enzymes, and protein oxidation in the diaphragm of humans is unknown. NAD(P)H oxidase, especially the Nox2 isoform, is an important source of ROS in the diaphragm. Our main hypothesis was that diaphragm from patients with HF have heightened Nox2 expression and p47
phox phosphorylation (marker of enzyme activation) that is associated with elevated protein oxidation. We collected diaphragm biopsies from patients with HF and brain-dead organ donors (controls). Diaphragm mRNA levels of Nox2 subunits were increased 2.5-4.6-fold over controls (p < 0.05). Patients also had increased protein levels of Nox2 subunits (p47phox , p22phox , and p67phox ) and total p47phox phosphorylation, while phospho-to-total p47phox levels were unchanged. The antioxidant enzyme catalase was increased in patients, whereas glutathione peroxidase and superoxide dismutases were unchanged. Among markers of protein oxidation, carbonyls were increased by ~40% (p < 0.05) and 4-hydroxynonenal and 3-nitrotyrosines were unchanged in patients with HF. Overall, our findings suggest that Nox2 is an important source of ROS in the diaphragm of patients with HF and increases in levels of antioxidant enzymes are not sufficient to maintain normal redox homeostasis. The net outcome is elevated diaphragm protein oxidation that has been shown to cause weakness in animals. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
12. Proteomic analysis of media from lung cancer cells reveals role of 14-3-3 proteins in cachexia.
- Author
-
McLean, Julie B., Moylan, Jennifer S., Horrell, Erin M. W., and Andrade, Francisco H.
- Subjects
PROTEOMICS ,LUNG cancer & genetics ,CANCER cells ,CACHEXIA ,MYOSIN ,EXTRACELLULAR matrix proteins ,PATIENTS - Abstract
Aims: At the time of diagnosis, 60% of lung cancer patients present with cachexia, a severe wasting syndrome that increases morbidity and mortality. Tumors secrete multiple factors that contribute to cachectic muscle wasting, and not all of these factors have been identified. We used Orbitrap electrospray ionization mass spectrometry to identify novel cachexia-inducing candidates in media conditioned with Lewis lung carcinoma cells (LCM). Results: One-hundred and 58 proteins were confirmed in three biological replicates. Thirty-three were identified as secreted proteins, including 14-3-3 proteins, which are highly conserved adaptor proteins known to have over 200 binding partners. We confirmed the presence of extracellular 14-3-3 proteins in LCM via western blot and discovered that LCM contained less 14-3-3 content than media conditioned with C2C12 myotubes. Using a neutralizing antibody, we depleted extracellular 14-3-3 proteins in myotube culture medium, which resulted in diminished myosin content. We identified the proposed receptor for 14-3-3 proteins, CD13, in differentiated C2C12 myotubes and found that inhibiting CD13 via Bestatin also resulted in diminished myosin content. Conclusions: Our novel findings show that extracellular 14-3-3 proteins may act as previously unidentified myokines and may signal via CD13 to help maintain muscle mass. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
13. Mitochondria dysfunction in lung cancer-induced muscle wasting in C2C12 myotubes.
- Author
-
McLean, Julie B., Moylan, Jennifer S., and Andrade, Francisco H.
- Subjects
CANCER research ,CACHEXIA ,MUSCLE fatigue ,MUSCLE strength ,MITOCHONDRIAL pathology - Abstract
Aims: Cancer cachexia is a syndrome which results in severe loss of muscle mass and marked fatigue. Conditioned media from cachexia-inducing cancer cells triggers metabolic dysfunction in skeletal muscle, including decreased mitochondrial respiration, which may contribute to fatigue. We hypothesized that Lewis lung carcinoma conditioned medium (LCM) would impair the mitochondrial electron transport chain (ETC) and increase production of reactive oxygen species, ultimately leading to decreased mitochondrial respiration. We incubated C2C12 myotubes with LCM for 30 min, 2, 4, 24 or 48 h. We measured protein content by western blot; oxidant production by 2',7'-dichlorofluorescin diacetate (DCF), 4-amino-5-methylamino-2',7'-difluorofluorescein diacetate (DAF), and MitoSox; cytochrome c oxidase activity by oxidation of cytochrome c substrate; and oxygen consumption rate (OCR) of intact myotubes by Seahorse XF Analyzer. Results: LCM treatment for 2 or 24 h decreased basal OCR and ATP-related OCR, but did not alter the content of mitochondrial complexes I, III, IV and V. LCM treatment caused a transient rise in reactive oxygen species (ROS). In particular, mitochondrial superoxide (MitoSOX) was elevated at 2 h. 4-Hydroxynonenal, a marker of oxidative stress, was elevated in both cytosolic and mitochondrial fractions of cell lysates after LCM treatment. Conclusion: These data show that lung cancer-conditioned media alters electron flow in the ETC and increases mitochondrial ROS production, both of which may ultimately impair aerobic metabolism and decrease muscle endurance. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
14. TNF signals via neuronal-type nitric oxide synthase and reactive oxygen species to depress specific force of skeletal muscle.
- Author
-
Stasko, Shawn A., Hardin, Brian J., Smith, Jeffrey D., Moylan, Jennifer S., and Reid, Michael B.
- Subjects
NITRIC oxide ,SKELETAL muscle ,CYTOPLASMIC filaments ,CATALASE ,METHYL formate - Abstract
TNF promotes skeletal muscle weakness, in part, by depressing specific force of muscle fibers. This is a rapid, receptor-mediated response, in which TNF stimulates cellular oxidant production, causing myofilament dysfunction. The oxidants appear to include nitric oxide (NO); otherwise, the redox mechanisms that underlie this response remain undefined. The current study tested the hypotheses that 1) TNF signals via neuronaltype NO synthase (nNOS) to depress specific force, and 2) musclederived reactive oxygen species (ROS) are essential co-mediators of this response. Mouse diaphragm fiber bundles were studied using live cell assays. TNF exposure increased general oxidant activity (P < 0.05; 2',7'-dichlorodihydrofluorescein diacetate assay) and NO activity (P < 0.05; 4-amino-5-methylamino-2',7'-difluorofluorescein diacetate assay) and depressed specific force across the full range of stimulus frequencies (1-300 Hz; P < 0.05). These responses were abolished by pretreatment with N
ω -nitro-L-arginine methyl ester (LNAME; a nonspecific inhibitor of NOS activity), confirming NO involvement. Genetic nNOS deficiency replicated L-NAME effects on TNF-treated muscle, diminishing NO activity (80%; P < 0.05) and preventing the decrement in specific force (P < 0.05). Comparable protection was achieved by selective depletion of muscle-derived ROS. Pretreatment with either SOD (degrades superoxide anion) or catalase (degrades hydrogen peroxide) depressed oxidant activity in TNF-treated muscle and abolished the decrement in specific force. These findings indicate that TNF signals via nNOS to depress contractile function, a response that requires ROS and NO as obligate co-mediators. [ABSTRACT FROM AUTHOR]- Published
- 2013
- Full Text
- View/download PDF
15. Doxorubicin acts via mitochondrial ROS to stimulate catabolism in C2C12 myotubes.
- Author
-
Gilliam, Laura A. A., Moylan, Jennifer S., Patterson, Elaine W., Smith, Jeffrey D., Wilson, Anne S., Rabbani, Zaheen, and Reid, Michael B.
- Abstract
Doxorubicin, a commonly prescribed chemotherapeutic agent, causes skeletal muscle wasting in cancer patients undergoing treatment and increases mitochondrial reactive oxygen species (ROS) production. ROS stimulate protein degradation in muscle by activating proteolytic systems that include caspase-3 and the ubiquitin-proteasome pathway. We hypothesized that doxorubicin causes skeletal muscle catabolism through ROS, causing upregulation of E3 ubiquitin ligases and caspase-3. We tested this hypothesis by exposing differentiated C2C12 myotubes to doxorubicin (0.2 μM). Doxorubicin decreased myotube width 48 h following exposure, along with a 40-50% reduction in myosin and sarcomeric actin. Cytosolic oxidant activity was elevated in myotubes 2 h following doxorubicin exposure. This increase in oxidants was followed by an increase in the E3 ubiquitin ligase atrogin-1/muscle atrophy F-box (MAFbx) and caspase-3. Treating myotubes with SS31 (opposes mitochondrial ROS) inhibited expression of ROS-sensitive atrogin-1/MAFbx and protected against doxorubicin-stimulated catabolism. These findings suggest doxorubicin acts via mitochondrial ROS to stimulate myotube atrophy. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
16. TNF/TNFR1 signaling mediates doxorubicin-induced diaphragm weakness.
- Author
-
Gilliam, Laura A. A., Moylan, Jennifer S., Ferreira, Leonardo F., and Reid, Michael B.
- Subjects
- *
DOXORUBICIN , *TUMOR necrosis factors , *CYTOKINES , *CELL membranes , *RESPIRATORY muscles - Abstract
Doxorubicin, a common chemotherapeutic agent, causes respiratory muscle weakness in both patients and rodents. Tumor necrosis factor-α (TNF), a proinflammatory cytokine that depresses diaphragm force, is elevated following doxorubicin chemotherapy. TNF-induced diaphragm weakness is mediated through TNF type 1 receptor (TNFR1). These findings lead us to hypothesize that TNF/TNFR1 signaling mediates doxorubicin-induced diaphragm muscle weakness. We tested this hypothesis by treating C57BL/6 mice with a clinical dose of doxorubicin (20 mg/kg) via intravenous injection. Three days later, we measured contractile properties of muscle fiber bundles isolated from the diaphragm. We tested the involvement of TNF/TNFR1 signaling using pharmaceutical and genetic interventions. Etanercept, a soluble TNF receptor, and TNFR1 deficiency protected against the depression in diaphragm-specific force caused by doxorubicin. Doxorubicin stimulated an increase in TNFR1 mRNA and protein (P < 0.05) in the diaphragm, along with colocalization of TNFR1 to the plasma membrane. These results suggest that doxorubicin increases diaphragm sensitivity to TNF by upregulating TNFR1, thereby causing respiratory muscle weakness. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
17. Doxorubicin acts through tumor necrosis factor receptor subtype 1 to cause dysfunction of murine skeletal muscle.
- Author
-
Gilliam, Laura A. A., Ferreira, Leonardo F., Bruton, Joseph D., Moylan, Jennifer S., Westerblad, Håkan, Clair, Daret K. St., and Reid, Michael B.
- Subjects
DOXORUBICIN ,TUMOR necrosis factors ,CANCER patients ,SERUM ,MUSCLES - Abstract
Cancer patients receiving doxorubicin chemotherapy experience both muscle weakness and fatigue. One postulated mediator of the muscle dysfunction is an increase in tumor necrosis factor-α (TNF), a proinflammatory cytokine that mediates limb muscle contractile dysfunction through the TNF receptor subtype 1 (TNFR1). Our main hypothesis was that systemic doxorubicin administration would cause muscle weakness and fatigue. Systemic doxorubicin administration (20 mg/kg) depressed maximal force of the extensor digitorum longus (EDL; P < 0.01), accelerated EDL fatigue (P < 0.01), and elevated serum TNF levels (P < 0.05) 72 h postinjection. Genetic TNFR1 deficiency prevented the fall in specific force caused by systemic doxorubicin, without protecting against fatigue (P < 0.01). These results demonstrate that clinical doxorubicin concentrations disrupt limb muscle function in a TNFR1-dependent manner. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
18. Physical inactivity and muscle weakness in the critically ill.
- Author
-
Chambers, Melissa A., Moylan, Jennifer S., and Reid, Michael B.
- Subjects
- *
PHYSICAL activity , *CRITICALLY ill , *INTENSIVE care units , *CRITICAL care medicine complications , *ASTHENIA , *PHYSICAL fitness , *HORMONE therapy , *NUTRITION , *PHYSIOLOGY , *THERAPEUTICS - Abstract
The article discusses a study which investigates the basis for weakness caused by inactivity and bed rest in patients in the intensive care unit (ICU). It states that weakness is boosted by various ICU-associated conditions including neuropathic changes, pharmacologic side effects, and physical inactivity. The results suggest the importance of countermeasures to reduce the effects of unloaded muscles to weakness which include physical activity, hormone therapy and nutritional supplements.
- Published
- 2009
- Full Text
- View/download PDF
19. Interleukin-1 stimulates catabolism in C2C12 myotubes.
- Author
-
Wei Li, Moylan, Jennifer S., Chambers, Melissa A., Smith, Jeffrey, and Reid, Michael B.
- Subjects
- *
INTERLEUKINS , *METABOLISM , *AFFERENT pathways , *UBIQUITIN , *NUCLEOTIDE sequence , *MUSCULAR atrophy , *PHOSPHORYLATION - Abstract
Interleukin-1 (IL-1) is an inflammatory cytokine that has been linked to muscle catabolism, a process regulated by muscle-specific E3 proteins of the ubiquitin-proteasome pathway. To address cellular mechanism, we tested the hypothesis that IL-1 induces myofibrillar protein loss by acting directly on muscle to increase expression of two critical E3 proteins, atrogin1/ muscle atrophy F-box (MAFbx) and muscle RING-finger 1 (MuRF1). Experiments were conducted using mature C2C 12 myotubes to eliminate systemic cytokine effects and avoid paracrine signaling by nonmuscle cell types. Time-course protocols were used to define the sequence of cellular responses. We found that atrogin1/MAFbx mRNA and MuRF1 mRNA are elevated 60-120 mm after myotube exposure to either IL-1α or IL-1β. These responses are preceded by signaling events that promote E3 expression. Both IL-1 isoforms stimulate phosphorylation of p38 mitogen-activated protein kinase and stimulate nuclear factor-κB (NF-κB) signaling; I-κB levels fall and NF-κB DNA binding activity increases. Other regulators of E3 expression are unaffected by IL-1 [cytosolic oxidant activity, Forkhead-O (Foxo) activity] or respond paradoxically (AKT). Chronic exposure of C2C 12 myotubes over 48 h resulted in reduced myotube width and loss of sarcomeric actin. We conclude that ILicr and IL-1β act via an oxidantand AKT/Foxo-independent mechanism to activate p38 MAPK, stimulate NF-κB signaling, increase expression of atrogin1/MAFbx and MuRF1, and reduce myofibrillar protein in differentiated myotubes. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
20. TNF-α acts via TNFR1 and muscle-derived oxidants to depress myofibrillar force in murine skeletal muscle.
- Author
-
Hardin, Brian J., Campbell, Kenneth S., Smith, Jeffrey D., Arbogast, Sandrine, Smith, Jacqueline, Moylan, Jennifer S., and Reid, Michael B.
- Subjects
TUMOR necrosis factors ,MUSCLES ,OXIDIZING agents ,DIAPHRAGM (Anatomy) ,LABORATORY mice - Abstract
Tumor necrosis factor-α (TNF) diminishes specific force of skeletal muscle. To address the mechanism of this response, we tested the hypothesis that TNF acts via the type 1 (TNFR1) receptor subtype to increase oxidant activity and thereby depress myofibnllar function. Experiments showed that a single intraperitoneal dose of TNF (100 μg/kg) increased cytosolic oxidant activity (P < 0.05) and depressed maximal force of male ICR mouse diaphragm by -25% within 1 h, a deficit that persisted for 48 h. Pretreating animals with the antioxidant Trolox (10 mg/kg) lessened oxidant activity (P < 0.05) and abolished contractile losses in TNF-treated muscle (P < 0.05). Genetic TNFR1 deficiency prevented the rise in oxidant activity and fall in force stimulated by TNF; type 2 TNF receptor deficiency did not. TNF effects on muscle function were evident at the myofibrillar level. Chemically permeabilized muscle fibers from TNF-treated animals had lower maximal Ca
2+ -activated force (P < 0.02) with no change in Ca2B sensitivity or shortening velocity. We conclude that TNF acts via TNFR1 to stimulate oxidant activity and depress specific force. TNF effects on force are caused, at least in part, by decrements in function of calcium-activated myofibrillar proteins. [ABSTRACT FROM AUTHOR]- Published
- 2008
- Full Text
- View/download PDF
21. IFN-γ does not mimic the catabolic effects of TNF-α.
- Author
-
Smith, Melissa A., Moylan, Jennifer S., Smith, Jeffrey D., Wei Li, and Reid, Michael B
- Subjects
- *
MEDICAL research , *CELL physiology , *MUSCLE cells , *CYTOKINES , *PHYSIOLOGY - Abstract
Cachexia is common in chronic inflammatory diseases and is attributed, in part, to an elevation of circulating proinflammatory cytokines. TNF-α is the prototype in this category. IFN-γ is also thought to play a role, but the evidence supporting this model is primarily indirect. To determine the direct effects of IFN-γ stimulation on muscle cells, we selected key components of the procatabolic signaling pathways by which TNF-α stimulates protein loss. We tested two hypotheses: I) IFN-γ mimics TNF-α signaling by increasing intracellular oxidant activity and activating MAPKs and NF-κB and 2) IFN-γ increases the expression of the ubiquitin ligases atrogin1/MAFbx and muscle-specific ring finger protein I (MuRFI). Results showed that treatment with IFN-γ at 60 ng/ml increased Stat1 phosphorylation after 15 mm, indicating receptor activation. IFN-γ had no effect on cytosolic oxidant activity, as measured by 2′,7′-dichlorofluorescein oxidation. Nor did IFN-γ activate JNK, ERK1/2, or p38 MAPK, as assessed by Western blot. Treatment for up to 60 mm did not decrease IKB-α protein levels, as measured by Western blot analysis, or the DNA binding activity of NF-κB, as measured by EMSA. After 6 h, IFN-γ decreased Akt phosphorylation and increased atrogin1/MAFbx and MuRF1 mRNA. Daily treatment for up to 72 h did not alter adult fast-type myosin heavy chain content or the total protein-to-DNA ratio. These data show that responses of myotubes to. IFN-γ and TNF-α differ markedly and provide little evidence for a direct catabolic effect of IFN-γ on muscle. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
22. Bowman-Birk inhibitor concentrate prevents atrophy, weakness, and oxidative stress in soleus muscle of hindlimb-unloaded mice.
- Author
-
Arbogast, Sandrine, Smith, Jacqueline, Matuszczak, Yves, Hardin, Brian J., Moylan, Jennifer S., Smith, Jeffrey D., Ware, Jeffrey, Kennedy, Ann R., and Reid, Michael B.
- Subjects
OXIDATIVE stress ,MICE ,MUSCLES ,REACTIVE oxygen species ,PLANT proteins ,HOMEOSTASIS - Abstract
Antigravity muscles atrophy and weaken during prolonged mechanical unloading caused by bed rest or spaceflight. Unloading also induces oxidative stress in muscle, a putative cause of weakness. We tested the hypothesis that dietary supplementation with Bowman-Birk inhibitor concentrate (BBIC), a soy protein extract, would oppose these changes. Adult mice were fed a diet supplemented with 1% BBIC during hindlimb unloading for up to 12 days. Soleus muscles of mice fed the BBIC- supplemented diet weighed less, developed less force per cross-sectional area, and developed less total force after unloading than controls. BBIC supplementation was protective, blunting decrements in soleus muscle weight and force. Cytosolic oxidant activity was assessed using 2′,7′-dichlorofluorescin diacetate. Oxidant activity increased in unloaded muscle, peaking at 3 days and remaining elevated through 12 days of unloading. Increases in oxidant activity correlated directly with loss of muscle mass and were abolished by BBIC supplementation. In vitro assays established that BBIC directly buffers reactive oxygen species and also inhibits serine protease activity. We conclude that dietary supplementation with BBIC protects skeletal muscle during prolonged unloading, promoting redox homeostasis in muscle fibers and blunting atrophy-induced weakness. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
23. Mechanical signal transduction in glucose transport of murine extensor digitorum longus (EDL) muscle.
- Author
-
Smith, Melissa Anne, Moylan, Jennifer S., and Reid, Michael B.
- Subjects
- *
CELLULAR signal transduction , *GLUCOSE , *BIOLOGICAL transport , *MUSCLES , *PROTEIN kinases , *ADENOSINE monophosphate , *PHOSPHORYLATION - Abstract
Contraction in skeletal muscle leads to increased endogenous ROS production, AMPK activation and increased glucose transport. Our current study tested the hypothesis that mechanical stimulation, i.e. stretch, is sufficient to increase AMPK phosphorylation and glucose transport and that these increases are ROS sensitive. We previously have shown that stretching EDL increases oxidant activity (+150%, p<0.0]), as measured by 2′,7′ dichlorofluorescein. This activity is suppressed by the ROS-specific antioxidants superoxide dismutase (SOD) and catalase (p<0.05). We show that stretching EDL increases AMPK phosphorylation (+164% control, p<0.05) as measured by immunoblotting with a phospho-specific antibody (Cell Signaling). This phosphorylation is suppressed by SOD and catalase (p<0.05). Finally, stretch increased glucose transport (+250% control, p<0.01), as measured by uptake of deoxy-D[1,2-³H]glucose. In contrast to AMPK activity, stretch-stimulated glucose transport was unaffected by SOD and catalase. These data demonstrate that while stretch-stimulated AMPK activity is ROS sensitive, stretch-stimulated glucose transport thus far appears to be ROS insensitive. Under these conditions, these data suggest that stretch-stimulated glucose transport may not be AMPK mediated. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
24. Muscle-specific calpastatin overexpression prevents diaphragm weakness in cecal ligation puncture-induced sepsis.
- Author
-
Supinski GS, Wang L, Song XH, Moylan JS, and Callahan LA
- Subjects
- Animals, Calpain metabolism, Cecum pathology, Ligation methods, Mice, Muscle Proteins metabolism, Muscle Weakness pathology, Muscles pathology, Myosin Heavy Chains metabolism, Sepsis pathology, Talin metabolism, Calcium-Binding Proteins metabolism, Cecum metabolism, Diaphragm metabolism, Diaphragm pathology, Muscle Weakness metabolism, Muscles metabolism, Sepsis metabolism
- Abstract
Recent work indicates that infections are a major contributor to diaphragm weakness in patients who are critically ill and mechanically ventilated, and that diaphragm weakness is a risk factor for death and prolonged mechanical ventilation. Infections activate muscle calpain, but many believe this is an epiphenomenon and that other proteolytic processes are responsible for infection-induced muscle weakness. We tested the hypothesis that muscle-specific overexpression of calpastatin (CalpOX; an endogenous calpain inhibitor) would attenuate diaphragm dysfunction in cecal ligation puncture (CLP)-induced sepsis. We studied 1) wild-type (WT) sham-operated mice, 2) WT CLP-operated mice, 3) CalpOX sham-operated mice, and 4) CalpOX CLP-operated mice (n = 9-10/group). Twenty-four hours after surgery, we assessed the diaphragm force-frequency relationship, diaphragm mass, and total protein content and diaphragm levels of talin and myosin heavy chain (MHC). CLP markedly reduced diaphragm-specific force generation (force/cross-sectional area), which was prevented by calpastatin overexpression (force averaged 21.4 ± 0.5, 6.9 ± 0.8, 22.4 ± 1.0, and 18.3 ± 1.3 N/cm(2), respectively, for WT sham, WT CLP, CalpOX sham, and CalpOX CLP groups, P < 0.001). Diaphragm mass and total protein content were similar in all groups. CLP induced talin cleavage and reduced MHC levels; CalpOX prevented these alterations. CLP-induced sepsis rapidly reduces diaphragm-specific force generation and is associated with cleavage and/or depletion of key muscle proteins (talin, MHC), effects prevented by muscle-specific calpastatin overexpression. These data indicate that calpain activation is a major cause of diaphragm weakness in response to CLP-induced sepsis., (Copyright © 2014 the American Physiological Society.)
- Published
- 2014
- Full Text
- View/download PDF
25. Neutral sphingomyelinase-3 mediates TNF-stimulated oxidant activity in skeletal muscle.
- Author
-
Moylan JS, Smith JD, Wolf Horrell EM, McLean JB, Deevska GM, Bonnell MR, Nikolova-Karakashian MN, and Reid MB
- Subjects
- Animals, Cell Line, Humans, Male, Mice, Mice, Inbred C57BL, Oxidation-Reduction, Muscle, Skeletal drug effects, Muscle, Skeletal metabolism, Oxidants metabolism, Sphingomyelin Phosphodiesterase metabolism, Tumor Necrosis Factor-alpha pharmacology
- Abstract
Aims: Sphingolipid and oxidant signaling affect glucose uptake, atrophy, and force production of skeletal muscle similarly and both are stimulated by tumor necrosis factor (TNF), suggesting a connection between systems. Sphingolipid signaling is initiated by neutral sphingomyelinase (nSMase), a family of agonist-activated effector enzymes. Northern blot analyses suggest that nSMase3 may be a striated muscle-specific nSMase. The present study tested the hypothesis that nSMase3 protein is expressed in skeletal muscle and functions to regulate TNF-stimulated oxidant production., Results: We demonstrate constitutive nSMase activity in skeletal muscles of healthy mice and humans and in differentiated C2C12 myotubes. nSMase3 (Smpd4 gene) mRNA is highly expressed in muscle. An nSMase3 protein doublet (88 and 85 kD) is derived from alternative mRNA splicing of exon 11. The proteins partition differently. The full-length 88 kD isoform (nSMase3a) fractionates with membrane proteins that are resistant to detergent extraction; the 85 kD isoform lacking exon 11 (nSMase3b) is more readily extracted and fractionates with detergent soluble membrane proteins; neither variant is detected in the cytosol. By immunofluorescence microscopy, nSMase3 resides in both internal and sarcolemmal membranes. Finally, myotube nSMase activity and cytosolic oxidant activity are stimulated by TNF. Both if these responses are inhibited by nSMase3 knockdown., Innovation: These findings identify nSMase3 as an intermediate that links TNF receptor activation, sphingolipid signaling, and skeletal muscle oxidant production., Conclusion: Our data show that nSMase3 acts as a signaling nSMase in skeletal muscle that is essential for TNF-stimulated oxidant activity.
- Published
- 2014
- Full Text
- View/download PDF
26. Sphingomyelinase depresses force and calcium sensitivity of the contractile apparatus in mouse diaphragm muscle fibers.
- Author
-
Ferreira LF, Moylan JS, Stasko S, Smith JD, Campbell KS, and Reid MB
- Subjects
- Animals, Antioxidants pharmacology, Cell Membrane Permeability, Cytosol enzymology, Diaphragm cytology, Diaphragm drug effects, Electric Stimulation, Excitation Contraction Coupling, Mice, Mice, Inbred C57BL, Mitochondria, Muscle enzymology, Muscle Fibers, Skeletal drug effects, Myofibrils enzymology, Oxidation-Reduction, Oxidative Stress, Phosphorylation, Protein Carbonylation, Protein Processing, Post-Translational, Reactive Oxygen Species metabolism, Tyrosine analogs & derivatives, Tyrosine metabolism, Calcium Signaling drug effects, Diaphragm enzymology, Muscle Contraction drug effects, Muscle Fibers, Skeletal enzymology, Muscle Strength drug effects, Sphingomyelin Phosphodiesterase metabolism
- Abstract
Diseases that result in muscle weakness, e.g., heart failure, are characterized by elevated sphingomyelinase (SMase) activity. In intact muscle, SMase increases oxidants that contribute to diminished muscle force. However, the source of oxidants, specific processes of muscle contraction that are dysfunctional, and biochemical changes underlying the weakness elicited by SMase remain unknown. We tested three hypotheses: 1) SMase-induced depression of muscle force is mediated by mitochondrial reactive oxygen species (ROS), 2) SMase depresses force and calcium sensitivity of the contractile apparatus, and 3) SMase promotes oxidation and phosphorylation of myofibrillar proteins. Our experiments included intact muscle bundles, permeabilized single fibers, and isolated myofibrillar proteins. The mitochondrial-targeted antioxidant d-Arg-2',6'-dimethyl-Tyr-Lys-Phe-NH(2), decreased cytosolic oxidants and protected intact muscle bundles from weakness stimulated by SMase. SMase depressed maximal calcium-activated force by 20% in permeabilized single fibers (in kN/m(2): control 117 ± 6; SMase 93 ± 8; P < 0.05). Calcium sensitivity of permeabilized single fibers decreased from 5.98 ± 0.03 (control) to 5.91 ± 0.02 (SMase; P < 0.05). Myofibrillar protein nitrotyrosines, carbonyls, and phosphorylation were unaltered by SMase. Our study shows that the fall in specific force of intact muscle elicited by SMase is mediated by mitochondrial ROS and can be attributed largely to dysfunction of the contractile apparatus.
- Published
- 2012
- Full Text
- View/download PDF
27. Prion protein expression and functional importance in skeletal muscle.
- Author
-
Smith JD, Moylan JS, Hardin BJ, Chambers MA, Estus S, Telling GC, and Reid MB
- Subjects
- Animals, Blotting, Western, Cell Line, Diaphragm metabolism, Humans, In Vitro Techniques, Mice, Mice, Transgenic, Oxidation-Reduction, Prions genetics, Muscle, Skeletal metabolism, Prions metabolism
- Abstract
Unlabelled: Skeletal muscle expresses prion protein (PrP) that buffers oxidant activity in neurons., Aims: We hypothesize that PrP deficiency would increase oxidant activity in skeletal muscle and alter redox-sensitive functions, including contraction and glucose uptake. We used real-time polymerase chain reaction and Western blot analysis to measure PrP mRNA and protein in human diaphragm, five murine muscles, and muscle-derived C2C12 cells. Effects of PrP deficiency were tested by comparing PrP-deficient mice versus wild-type mice and morpholino-knockdown versus vehicle-treated myotubes. Oxidant activity (dichlorofluorescin oxidation) and specific force were measured in murine diaphragm fiber bundles., Results: PrP content differs among mouse muscles (gastrocnemius>extensor digitorum longus, EDL>tibialis anterior, TA; soleus>diaphragm) as does glycosylation (di-, mono-, nonglycosylated; gastrocnemius, EDL, TA=60%, 30%, 10%; soleus, 30%, 40%, 30%; diaphragm, 30%, 30%, 40%). PrP is predominantly di-glycosylated in human diaphragm. PrP deficiency decreases body weight (15%) and EDL mass (9%); increases cytosolic oxidant activity (fiber bundles, 36%; C2C12 myotubes, 7%); and depresses specific force (12%) in adult (8-12 mos) but not adolescent (2 mos) mice., Innovation: This study is the first to directly assess a role of prion protein in skeletal muscle function., Conclusions: PrP content varies among murine skeletal muscles and is essential for maintaining normal redox homeostasis, muscle size, and contractile function in adult animals.
- Published
- 2011
- Full Text
- View/download PDF
28. TNF-alpha acts via TNFR1 and muscle-derived oxidants to depress myofibrillar force in murine skeletal muscle.
- Author
-
Hardin BJ, Campbell KS, Smith JD, Arbogast S, Smith J, Moylan JS, and Reid MB
- Subjects
- Animals, Antioxidants pharmacology, Calcium metabolism, Chromans pharmacology, Diaphragm drug effects, Diaphragm innervation, Electric Stimulation, Injections, Intraperitoneal, Male, Mice, Mice, Inbred ICR, Mice, Knockout, Myofibrils drug effects, Receptors, Tumor Necrosis Factor, Type I deficiency, Receptors, Tumor Necrosis Factor, Type I genetics, Receptors, Tumor Necrosis Factor, Type II metabolism, Time Factors, Tumor Necrosis Factor-alpha administration & dosage, Diaphragm metabolism, Muscle Contraction drug effects, Muscle Strength drug effects, Myofibrils metabolism, Oxidative Stress drug effects, Receptors, Tumor Necrosis Factor, Type I metabolism, Signal Transduction drug effects, Tumor Necrosis Factor-alpha metabolism
- Abstract
Tumor necrosis factor-alpha (TNF) diminishes specific force of skeletal muscle. To address the mechanism of this response, we tested the hypothesis that TNF acts via the type 1 (TNFR1) receptor subtype to increase oxidant activity and thereby depress myofibrillar function. Experiments showed that a single intraperitoneal dose of TNF (100 microg/kg) increased cytosolic oxidant activity (P < 0.05) and depressed maximal force of male ICR mouse diaphragm by approximately 25% within 1 h, a deficit that persisted for 48 h. Pretreating animals with the antioxidant Trolox (10 mg/kg) lessened oxidant activity (P < 0.05) and abolished contractile losses in TNF-treated muscle (P < 0.05). Genetic TNFR1 deficiency prevented the rise in oxidant activity and fall in force stimulated by TNF; type 2 TNF receptor deficiency did not. TNF effects on muscle function were evident at the myofibrillar level. Chemically permeabilized muscle fibers from TNF-treated animals had lower maximal Ca2+-activated force (P < 0.02) with no change in Ca2+ sensitivity or shortening velocity. We conclude that TNF acts via TNFR1 to stimulate oxidant activity and depress specific force. TNF effects on force are caused, at least in part, by decrements in function of calcium-activated myofibrillar proteins.
- Published
- 2008
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.